NDC codes

382549 NDC codes with hospital pricing data in the network.

• NDC 00264-1800-32 — SODIUM CHLORIDE 0.9 % IV SOLN (140 hospitals, 3,306–4,332 samples)
• NDC 00009004727 — METHYLPREDNISOLONE SOD SUCC (PF) 125 MG/2 ML SOLUTION FOR INJECTION (96 hospitals, 2,554–4,327 samples)
• NDC 63323041115 — MIDAZOLAM 1 MG/ML INJECTION SOLUTION (114 hospitals, 1,756–4,321 samples)
• NDC 67457045720 — famotidine 10 mg/mL solution 20 mL Vial (71 hospitals, 3,788–4,319 samples)
• NDC 00069024801 — 1 VIAL in 1 CARTON (0069-0248-01) / 100 mL in 1 VIAL (100 hospitals, 3,155–4,316 samples)
• NDC 00143938001 — Midazolam-Sodium Chloride (99 hospitals, 1,520–4,310 samples)
• NDC 65250-0266-09 — BUPIVACAINE LIPOSOME(PF) 1.3 %(13.3 MG/ML) SUSPENSION FOR INFILTRATION (93 hospitals, 4,282–4,309 samples)
• NDC 67457044843 — Famotidine Inj 10 MG/ML,Famotidine Inj 20 MG/2ML,Famotidine Inj 40 MG/4ML,Famotidine Inj 200 MG/20ML,Famotidine Inj 500 MG/50ML,Famotidine Preservative Free Inj 20 MG/2ML (53 hospitals, 3,787–4,309 samples)
• NDC 00409-1163-01 — BUPIVACAINE HCL 0.5 % (5 MG/ML) INJECTION SOLUTION (90 hospitals, 4,061–4,304 samples)
• NDC 17478054005 — 17478-0540-05 - hydromorphone 50. Soln (109 hospitals, 2,168–4,301 samples)
• NDC 0264780020 — NaCl 0.9% 0.9 % Soln 250 mL Flex Cont (48 hospitals, 521–4,301 samples)
• NDC 0338004902 — SODIUM CHLORIDE 0.9 % IV SOLP (49 hospitals, 521–4,301 samples)
• NDC 7629700132 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (SO) (22 hospitals, 521–4,301 samples)
• NDC 00641620901 — MIDAZOLAM HCL 2 MG/2ML IJ SOLN (66 hospitals, 1,745–4,301 samples)
• NDC 00641602101 — FAMOTIDINE 10 MG/ML INTRAVENOUS SOLUTION (44 hospitals, 3,786–4,299 samples)
• NDC 00641602110 — FAMOTIDINE 10 MG/ML INJ SOLUTION (MULTI-VIAL SIZE) (49 hospitals, 3,786–4,299 samples)
• NDC 47426-0201-01 — APREPITANT 130 MG/18 ML (7.2 MG/ML) INTRAVENOUS EMULSION (135 hospitals, 4,144–4,297 samples)
• NDC 00409765052 — heparin 100 Units/mL in 0.45 NS Inj 250 mL Flex Cont (138 hospitals, 552–4,296 samples)
• NDC 00591213680 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSION (28 hospitals, 3,153–4,296 samples)
• NDC 00409672924 — MAGNESIUM SULF 40 MG/ML INJ (216 hospitals, 1,827–4,293 samples)
• NDC 77725-4593-03 — FENTANYL CITRATE (PF) 50 MCG/ML INJECTION (WRAPPER) (1 hospital, 4,008–4,278 samples)
• NDC 00169183311 — insulin regular 0.02 unit/mL-D10W Bolus (Peripheral) (210 hospitals, 1,595–4,277 samples)
• NDC 27808008602 — Hydrocodone Polistirex And Chlorpheniramine Polistirex Extended-Release: 473 Ml In 1 Bottle (27808-086-02) (116 hospitals, 4,149–4,275 samples)
• NDC 00904-6797-61 — lisinopril 5mg tablet (154 hospitals, 4,049–4,274 samples)
• NDC 00591544301 — ALBUTEROL SULFATE (2.5 MG/3ML) 0.083% IN NEBU (57 hospitals, 3,378–4,269 samples)
• NDC 63323041218 — MIDAZOLAM HCL 5 MG/ML IJ SOLN (ALL SIZES) (108 hospitals, 1,730–4,268 samples)
• NDC 50242-0145-01 — PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION (250 hospitals, 3,970–4,267 samples)
• NDC 25021010899 — CEFTRIAXONE 10 GRAM SOLUTION FOR INJECTION (59 hospitals, 3,120–4,263 samples)
• NDC 00409158219 — BUPIVACAINE (PF) 0.75 % (7.5 MG/ML) INJECTION SOLUTION (83 hospitals, 1,866–4,260 samples)
• NDC 00591505210 — PREDNISONE 5 MG TABLET (22 hospitals, 3,377–4,259 samples)
• NDC 63323048357 — LIDOCAIN/EPI 1MG INJ (202 hospitals, 2,772–4,257 samples)
• NDC 23155024041 — 23155-0240-41 - metoclopramide 5 mg/mL Soln (300 hospitals, 1,059–4,254 samples)
• NDC 00054317757 — DEXAMETHASONE SOLN 0.5 MG/5ML (94 hospitals, 3,314–4,250 samples)
• NDC 68982-0850-02 — IMMUNE GLOBULIN, GAMMA (IGG) (10 %)-MALT-IGA OVER 50 MCG/ML INTRAVENOUS SOLUTION (94 hospitals, 4,248 samples)
• NDC 00006-5425-15 — SUGAMMADEX 100 MG/ML INTRAVENOUS SOLUTION (77 hospitals, 4,047–4,245 samples)
• NDC 63323048807 — Lidocaine Inj 1.5% w/ Epinephrine-1:200000 (PF) (83 hospitals, 2,715–4,245 samples)
• NDC 72611-0749-10 — MIDAZOLAM 5 MG/ML INTRANASAL SOLUTION (38 hospitals, 3,657–4,242 samples)
• NDC 00069020910 — propofol 10 mg/mL infusion set 20 mL Vial (149 hospitals, 3,044–4,241 samples)
• NDC 00641-6061-25 — MIDAZOLAM 5 MG/ML INJECTION SOLUTION (52 hospitals, 3,746–4,241 samples)
• NDC 51754-0501-03 — CAFFEINE CITRATE 60 MG/3 ML (20 MG/ML) ORAL SOLUTION (65 hospitals, 4,122–4,239 samples)
• NDC 63739-0645-10 — FAMOTIDINE 20 MG TABLET (112 hospitals, 4,042–4,231 samples)
• NDC 00409189303 — MORPHINE 10 MG/ML IV SYRG (133 hospitals, 775–4,231 samples)
• NDC 00406-0552-23 — OXYCODONE 5 MG TABLET (59 hospitals, 4,042–4,231 samples)
• NDC 68084-0753-25 — CYCLOBENZAPRINE 5 MG TABLET (59 hospitals, 3,985–4,228 samples)
• NDC 00054472825 — Prednisone Tab 5 Mg - 00054472825 (37 hospitals, 3,301–4,228 samples)
• NDC 00641602825 — Fentanyl Citrate: 25 Vial In 1 Carton (0641-6028-25) / 5 Ml In 1 Vial (0641-6028-01) (69 hospitals, 2,400–4,227 samples)
• NDC 00703001801 — Hydromorphone Hydrochloride: 1 Vial In 1 Carton (0703-0018-01) / 50 Ml In 1 Vial (102 hospitals, 1,563–4,227 samples)
• NDC 17271070106 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (90 hospitals, 1,725–4,218 samples)
• NDC 00409490434 — Lidocaine HCl (Cardiac) IV Soln Pref Syr 50 MG/5ML (1%) (63 hospitals, 3,345–4,218 samples)
• NDC 00990-7983-02 — Sodium Chloride (95 hospitals, 2,732–4,217 samples)